Immunohistochemical distribution of tubulin beta II in human normal and neoplastic tissues

Kurume Medical Journal

Volumn 52, Issue 4, 2005, Pages 117-125

  Oda, Eriko ^a   Nakamura, Yasuhiro ^b   Yamamoto, Munehiko ^a   Kojiro, Masamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARY S HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Monoclonal antibody KNY379; Neoplasm; Normal tissues; Tubulin beta

Indexed keywords

BETA TUBULIN; MONOCLONAL ANTIBODY; PROTEIN TUBULIN BETA 2; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BASAL CELL CARCINOMA; CANCER TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT MESOTHELIOMA; NEPHROBLASTOMA; ORGAN DISTRIBUTION; PANCREAS CARCINOMA; PLEOMORPHIC ADENOMA; PROTEIN LOCALIZATION; WARTHIN TUMOR; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS; PROTEIN ISOFORMS; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33645795236     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.52.117     Document Type: Article

References (34)

1. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ et al. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell 1980;20:95-105.
2. Sulivan KF. Structure and utilization of tubulin isotypes. Ann Rev Cell Biol 1988; 4:687-716.
3. Roach MC, Boucher VL. Walss C, Ravdin PM, and Luduena RF. Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissues. Cell Motil Cytoskeleton 1998; 39:273-285.
4. Wang D, Villasante A, Lewis SA, and Cowan NJ. The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous beta-tubulin isotype. J Cell Biol 1986; 103:1903-1910.
5. Lewis SA, Gilmartin ME, Hall JL, and Cowan NJ. Three expressed sequences within the human beta-tubulin multigene family each define a distinct isotype. J Mol Biol 1985; 182:11-20.
6. Banerjee A, Roach MC, Wall KA, Lopata MA, Clevaland DW et al. A monoclonal antibody against the type II isotype of beta-tubulin. J Biol Chem 1998; 263:3029-3034.
7. Nakamura Y, Yamamoto M, Oda E, Yamamoto A, Kanemura Y et al. Expression of tubulin beta II in neural stem/progenitor cells and radial fibers during human fetal brain development. Lab Invest 2003; 83:479-489.
8. Lewis SA, Lee M, and Cowan NJ. Five mouse tubulin isotypes and their regulated expression during development. J Cell Biol 1985; 101:852-861.
9. Roberson MD, Toews AD, Goodrum JF, and Morell P. Neurofilament and tubulin mRNA expression in Schwann cells. J Neurosci Res 1992; 33:156-162.
10. Oblinger MM, and Kost SA. Coordinate regulation of tubulin and microtubule associated protein genes during development of hamster brain. Brain Res Dev Brain Res 1994;77:45-54.
11. Moskowitz PF, and Oblinger MM. Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain. Brain Res Mol Brain Res 1995; 30:211-222.
12. Paden CM, Zhou X, Watt JA, Burton R, Pickett J et al. Distribution of growth-associated class I alpha-tubulin and class II beta-tubulin mRNAs in adult rat brain. J Comp Neurol 1995; 362:368-384.
13. Moody SA, Miller V, Spanos A, and Frankfurter A. Developmental expression of a neuron-specific beta-tubulin in frog (Xenopus laevis): a marker for growing axons during the embryonic period. J Comp Neurol 1996; 364:219-230.
14. Hallworth R, and Luduena RF. Differential expression of beta tubulin isotypes in the adult gerbil cochlea. Hear Res 2000; 148:161-172.
15. Arai K, Maruo K, Ara KY, Uehara K, and Matsuda H. Characterization of isotype-specific regions of five classes of canine beta-tubulin and their expression in several tissues and cell culture. J Vet Med Sci 2001; 63:1297-1302.
16. Arai K, Shibutani M, and Matsuda H. Distribution of the class II beta-tubulin in developmental and adult rat tissues. Cell Motil Cytoskeleton 2002; 52:174-182.
17. Ranganathan S, Salazar H, Benetatos CA, and Hudes GR. Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. The Prostate 1997; 30:263-268.
18. Walss-Bass C, Kreisberg JI, and Luduena RF. Mechanism of localization of beta II-tubulin in the nuclei of cultured rat kidney mesangial cells. Cell Motil Cytoskeleton 2001; 49:208-217.
19. Walss-Bass C, Xu K, David S, Fellous A, and Luduena RF. Occurrence of nuclear beta II-tubulin in cultured cells. Cell Tissue Res 2002; 308:215-223.
20. Xu K, and Luduena RF. Characterization of nuclear beta II-tubulin in tumor cells: a possible novel target for taxol. Cell Motil Cytoskeleton 2002; 53:39-52.
21. Dozier JH, Hiser L, Davis JA, Thomas NS, Tucci MA et al. Beta II tubulin predominates in normal and tumor breast tissues. Brest Cancer Res 2003; 5:157-169.
22. Nakamura Y, Yamamoto M, and Kumamaru E. A variant very low density lipoprotein receptor lacking 84 base pairs of O- linked sugar domain in the human brain myelin. Brain Res 1998; 793:47-53.
23. Katsetos CD, Herman MM, and Mork SJ. Class III beta-tubulin in human development and cancer. Cell Motil Cytoskelton 2003; 55:77-96.
24. Roach MC, Boucher VL, Walss C, Ravdin PM, and Luduena RF. Preparation of a monoclonal antibody specific for the class I isotype of beta tubulin. Cell Motil Cytoskelton 1998; 39:273-285.
25. Arai K, Nakano H, Shibutani M, Naoi M, and Matsuda H. Expression of class II beta tubulin by proliferative myoepithelial cells in canine mammary mixed tumors. Vet Pathol 2003; 40:670-676.
26. Chang K, Pai LH, Pass H, Pogrebniak HW, Tsao MS et al. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 1992; 16:259-268.
27. Yamada T, Jiping J, Endo R, Gotoh M, Shimosato Y et al. Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: its identification as vascular cell adhesion molecule 1. Br J Cancer 1995; 71:562-570.
28. Doglioni C, Tos AP, Laurino L, luzzolino P, Chiarelli C et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20:1037-1046.
29. Noguchi M, Nakajima T, Hirohashi S, Akiba T, and Shimosato Y. Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti surfactant apoprotein, ant-Lewisa, and anti-Tn antibody. Hum pathol 1989; 20:53-57.
30. Churg A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 1985; 9:360-365.
31. Don S, Verrills NM, Liaw TY, Liu ML, Norris MD et al. Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs. Mol Cancer Ther 2004; 3:1137-1146.
32. Dumontet C, Isaac S, Souquet PJ, Bejui-Thivolet F, Pacheco Y et al. Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. Bull Cancer 2005; 92:E25-30.
33. Petitclerc E, Deschesnes RG, Cote MF, Marquis C, Janvier R et al. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Cancer Res 2004; 64:4654-4663.
34. Derry WB, Wilson L, Khan IA, Luduena RF, and Jordan MA. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry 1997; 36:3554-3562.